logo

Fragile X: Developing targeted treatments

A new NeuroTherapeutics Research Institute will develop targeted treatments for neurodegenerative disorders, such as fragile X-associated tremor/ataxia syndrome, or FXTAS, discovered by UC Davis research team Randi and Paul Hagerman.

back pipe next

 


Welcome
 
New! Nursing school
 
Discovering
 
yellow dotCancer
yellow dotAutism
yellow dotInfectious disease
yellow dotStem cell
yellow dotFragile X
yellow dotClinical and Translational
Science Center
 
Healing
 
Learning
 
Reaching out
 
Working
 
Visiting
  UC Davis Health System | Maps and Directions | Contact Us | © 2007 UC Regents